HUBEI BIOCAUSE PHARMACEUTICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.31 CNY | +0.87% |
|
-2.94% | -18.66% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Hubei Biocause Pharmaceutical Co.,Ltd. is a China-based company principally engaged in insurance business, such as life insurance, health insurance and casualty insurance. The Company is also involved in pharmaceutical business and chemical business. The Companyâs products include polypropylene and Ibuprofen. The Company distributes its products in domestic market and to overseas markets, with Central China and South China as its main markets.
Sector
Life & Health Insurance
Calendar
24/05/2024
- Annual General Meeting
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -18.66% | 1.57B | |
| +13.43% | 78.69B | |
| +9.69% | 50.96B | |
| +3.49% | 48.2B | |
| +20.18% | 43.97B | |
| +13.73% | 41.9B | |
| +26.04% | 39.87B | |
| +6.85% | 30.84B | |
| -1.87% | 29.08B | |
| +13.01% | 23.04B |
- Stock Market
- Equities
- 000627 Stock
- News Hubei Biocause Pharmaceutical Co., Ltd.
- Hubei Biocause Pharmaceutical Gets Regulatory Nod for Ibuprofen; Shares Down 5%